comprehensive -WSS

comprehensive

author：hotspot 2025-08-11 11:44:12 - browse：8

ANDREW YATES/AFP via Getty Images

WASHINGTON — A federal judge in Delaware on Friday ruled against AstraZeneca in a case challenging the constitutionality of Medicare’s new drug price negotiation program.

Colm Connolly, chief judge of the U.S. District Court of Delaware, ruled against the company on all its major arguments. He wrote that AstraZeneca had not proved that Medicare’s new drug price negotiation program jeopardizes its constitutional property rights, and that the company didn’t have standing to challenge the guidance Medicare issued to implement the program.

The case is the first of a slew of cases filed by the pharmaceutical industry and its allies to be decided at the district court level. The Delaware ruling is a blow, as several of the other cases made similar arguments about how the program violates drugmakers’ constitutional property rights.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： What drug price negotiations mean for Medicare Part D

WSS

Listen: Biogen's potential pivot, & Illumina's next chapter

Feds fine Medicare Advantage plans for overcharging members

How Long Island became the ‘eugenics capital of the world’

Appeals court upholds limits to abortion pill

CDC advisory panel says seniors 'may' get RSV vaccine

How to fix cancer clinical trials' diversity problem

leisure time

comprehensive

explore

Moonlake's readout produced a cash windfall. Risks remain

Why more medical students aren't specializing in primary care

Duchenne breakthrough therapy leaves behind pioneering families

What do new weight loss drugs mean for bariatric surgery?

Dobbs anniversary: the lost opportunity of abortion as health care

ALS advocates say criticism of new drugs misses bigger picture

Medical leaders decry Supreme Court decision on affirmative action

What drug price negotiations mean for Medicare Part D

Drug repurposing or repositioning? The language matters

Neuroscience startup Neumora files for IPO

leisure time

Stem cell treatment guidelines are released by FDA

How Long Island became the ‘eugenics capital of the world’

How a symptom of dementia informs our understanding of creativity

Drug firms test therapies to halt Alzheimer’s before symptoms arise

Complete sequence of Y chromosome published for first time

Complete sequence of Y chromosome published for first time

Wikipedia

hotspot

leisure time

hotspot